GO:0006543 L-glutamine catabolic process: Glutamine Breakdown Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006543 (L-glutamine catabolic process) describes the chemical reactions and pathways that break down L-glutamine into glutamate and ammonia, feeding carbon and nitrogen into central metabolism.
• Glutamine is the most abundant free amino acid in plasma and is a major nitrogen carrier and anaplerotic substrate for rapidly dividing cells.
• Catabolism of glutamine supports nucleotide biosynthesis, glutathione production, and redox homeostasis in proliferating and stressed cells.
• Dysregulated glutamine catabolism is a metabolic hallmark of many cancers and is being pursued as a therapeutic target.
• Key enzymes include GLS (glutaminase), GLUD1/GLUD2 (glutamate dehydrogenases), and transaminases such as GOT1/GOT2 and GPT/GPT2.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of glutamine catabolic genes in disease and metabolism.
Description
L-glutamine catabolic process (GO:0006543) is the set of biochemical reactions that degrade L-glutamine, releasing glutamate and ammonia and channeling carbon and nitrogen into central metabolic pathways. Glutamine is the most abundant free amino acid in human plasma and serves as a primary inter-organ nitrogen shuttle and a preferred respiratory fuel for enterocytes and lymphocytes. Because of this central role, the breakdown of glutamine is tightly linked to cell proliferation, redox balance, and biosynthetic capacity. Researchers study GO:0006543 to understand how normal and diseased cells rewire nitrogen and carbon flux, and to identify metabolic vulnerabilities that can be exploited therapeutically. The pathway is also relevant to nutrition and clinical supplementation, since glutamine is used in parenteral nutrition and in disease settings such as sickle cell disease. In this article we summarize the definition, mechanism, key genes, disease links, and CRISPR-based research methods for L-glutamine catabolic process, based on published literature and the QuickGO definition.
L-glutamine catabolic process At A Glance
| GO ID | GO:0006543 |
|---|---|
| GO term | L-glutamine catabolic process |
| Ontology | biological_process |
| Synonym | glutamine breakdown; glutamine catabolism; glutamine degradation |
| Major function | Breakdown of L-glutamine to glutamate and ammonia, feeding carbon and nitrogen into central metabolism |
| Substrates | L-glutamine, water, NAD(P)+, alpha-keto acids |
| Products | Glutamate, ammonia, alpha-ketoglutarate, NAD(P)H |
| Key enzymes | GLS, GLS2, GLUD1, GLUD2, GOT1, GOT2, GPT, GPT2 |
| Cellular locations | Cytosol, mitochondria |
| Related pathways | Glutathione metabolism, TCA cycle, nucleotide biosynthesis, redox homeostasis |
What Is GO:0006543?
According to the Gene Ontology, L-glutamine catabolic process (GO:0006543) is defined as the chemical reactions and pathways resulting in the breakdown of L-glutamine. In practice, this includes enzymatic deamidation of glutamine to glutamate and ammonia, oxidative deamination of glutamate to alpha-ketoglutarate, and transamination reactions that transfer glutamine-derived nitrogen to other acceptors. These reactions feed the tricarboxylic acid (TCA) cycle, support glutathione synthesis, and supply nitrogen for nucleotide and amino acid biosynthesis.
Why Is L-glutamine catabolic process Important in Cell Biology?
L-glutamine catabolic process is important because it sits at the intersection of nitrogen handling, carbon anaplerosis, and redox control, all of which are essential for cell growth and survival. Many cancer cells depend on glutamine catabolism to sustain proliferation, and targeting this pathway is an active therapeutic strategy. In addition, glutamine breakdown supports glutathione synthesis and protects cells from oxidative stress, as shown in exercise-trained rats and porcine enterocytes. Clinically, glutamine supplementation is used in parenteral nutrition and in sickle cell disease, making its catabolism relevant to nutrition and hematology.
• Provides nitrogen for nucleotide and amino acid biosynthesis in proliferating cells.
• Supplies alpha-ketoglutarate to the TCA cycle for energy and anaplerosis.
• Supports glutathione synthesis and redox homeostasis.
• Is a metabolic vulnerability in many cancers, making it a drug target.
• Influences immune and intestinal cell function through glutamine availability.
• Relevant to parenteral nutrition formulations containing glutamine dipeptides.
• Linked to sickle cell disease pathophysiology and glutamine supplementation.
• Affects insulin secretion indirectly via amino acid metabolism in some species.
• Industrial production of L-glutamine highlights its commercial and clinical importance.
• Serves as a model pathway for studying metabolic flux and enzyme regulation.
What Happens During L-glutamine catabolic process?
Deamidation of glutamine to glutamate
In simple terms: Glutamine loses an ammonia group to become glutamate.
The first committed step in L-glutamine catabolism is the hydrolysis of glutamine to glutamate and ammonia, catalyzed by glutaminase enzymes such as GLS and GLS2. This reaction releases nitrogen that can be used for biosynthetic processes and generates glutamate, a central metabolite. In cancer cells, increased glutaminase activity supports proliferation and is a target for inhibitors.
Oxidative deamination of glutamate
In simple terms: Glutamate is converted to alpha-ketoglutarate, releasing more ammonia.
Glutamate dehydrogenase (GLUD1 and GLUD2) catalyzes the oxidative deamination of glutamate to alpha-ketoglutarate and ammonia, using NAD+ or NADP+ as cofactor. Alpha-ketoglutarate enters the TCA cycle for energy production and anaplerosis. This step links glutamine catabolism to mitochondrial metabolism and redox balance.
Transamination reactions
In simple terms: Glutamine-derived nitrogen is transferred to other molecules.
Transaminases such as GOT1, GOT2, GPT, and GPT2 transfer amino groups from glutamate to alpha-keto acids, producing other amino acids like aspartate and alanine. These reactions are important for nitrogen shuttling between cytosol and mitochondria and for maintaining metabolic balance. They also support nucleotide biosynthesis by providing nitrogen donors.
Glutathione synthesis and redox control
In simple terms: Glutamine breakdown helps make antioxidants.
Glutamate derived from glutamine is a substrate for glutathione synthesis, which protects cells from oxidative stress. In endurance-exercise trained rats, L-glutamine supplementation enhanced the liver glutamine-glutathione axis and heat shock factor-1 expression. In porcine enterocytes, L-glutamine attenuated apoptosis by regulating glutathione-related redox homeostasis.
Anaplerotic feeding of the TCA cycle
In simple terms: Glutamine breakdown refills the energy cycle.
The conversion of glutamine to alpha-ketoglutarate provides anaplerotic carbon for the TCA cycle, supporting ATP production and biosynthetic precursors. This is particularly important in rapidly dividing cells that consume TCA intermediates for biosynthesis. Targeting this anaplerotic flux is a strategy in cancer therapy.
Key Genes Involved in GO:0006543 L-glutamine catabolic process
The following genes encode enzymes and transporters directly involved in L-glutamine catabolic process and related metabolic pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GLS | Glutaminase; converts glutamine to glutamate | Target in cancer metabolism; knockout reduces proliferation |
| GLS2 | Glutaminase; converts glutamine to glutamate | Liver-specific isoform; roles in redox and tumor suppression |
| GLUD1 | Glutamate dehydrogenase; glutamate to alpha-ketoglutarate | Regulates ammonia handling and TCA anaplerosis |
| GLUD2 | Glutamate dehydrogenase; glutamate to alpha-ketoglutarate | Neural and mitochondrial metabolism |
| GOT1 | Cytosolic aspartate aminotransferase | Nitrogen shuttling and redox balance |
| GOT2 | Mitochondrial aspartate aminotransferase | Malate-aspartate shuttle and TCA cycle |
| GPT | Alanine aminotransferase | Nitrogen transfer and gluconeogenesis |
| GPT2 | Alanine aminotransferase 2 | Mitochondrial nitrogen metabolism |
| SLC1A5 | Glutamine transporter | Uptake of glutamine for catabolism |
| SLC7A5 | L-type amino acid transporter | Glutamine efflux and leucine uptake |
| SLC38A1 | Glutamine transporter | Glutamine flux in neurons and cancer |
| SLC38A2 | Glutamine transporter | Nutrient sensing and mTORC1 activation |
| GCLC | Glutamate-cysteine ligase catalytic subunit | Glutathione synthesis from glutamate |
| GCLM | Glutamate-cysteine ligase modifier subunit | Glutathione synthesis regulation |
| GSS | Glutathione synthetase | Glutathione production |
| G6PD | Glucose-6-phosphate dehydrogenase | NADPH supply for redox and glutamine metabolism |
| IDH1 | Isocitrate dehydrogenase 1 | Cytosolic NADPH and alpha-ketoglutarate |
How Is L-glutamine catabolic process Regulated?
L-glutamine catabolic process is regulated at multiple levels. Expression of GLS is controlled by oncogenes such as MYC, which promotes glutamine dependence in cancer cells. Nutrient availability and mTORC1 signaling influence glutamine uptake and catabolism through transporters like SLC38A2 and SLC1A5. Ammonia produced by glutaminase and glutamate dehydrogenase can feedback-inhibit enzyme activity and affect cellular pH. Redox status also regulates the pathway, as glutathione demand modulates glutamate utilization. In addition, hormonal and nutritional factors influence glutamine metabolism in whole organisms, as seen in parenteral nutrition studies.
L-glutamine catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GLS | Cancer proliferation and glutamine addiction | Knockout in cancer cell lines; xenograft models |
| GLUD1 | Hyperinsulinism/hyperammonemia syndrome | Point mutation knock-in in mice or cells |
| GOT1 | Pancreatic cancer redox balance | Knockout and rescue in cell lines |
| SLC1A5 | Cancer glutamine uptake | Overexpression and knockout in cancer cells |
| GCLC | Oxidative stress and glutathione deficiency | Knockout in enterocytes or hepatocytes |
Cancer metabolism
Many cancer cells exhibit increased glutamine catabolism to support proliferation, redox balance, and biosynthetic demands. Targeting glutaminase or glutamate dehydrogenase is a therapeutic strategy in multiple cancers. High glutamine flux is associated with oncogenic MYC and other drivers.
Sickle cell disease
L-glutamine supplementation has been explored in sickle cell disease for its effects beyond redox, including potential effects on adhesion and inflammation. The catabolism of glutamine may influence these pathways, though mechanisms are still under study.
Intestinal and immune function
Glutamine is a key fuel for enterocytes and immune cells, and its catabolism supports gut barrier function and immune responses. In porcine enterocytes, L-glutamine attenuated apoptosis via glutathione-related redox homeostasis.
Exercise and oxidative stress
In endurance-exercise trained rats, L-glutamine supplementation enhanced the liver glutamine-glutathione axis and heat shock factor-1 expression, suggesting a role in managing oxidative stress.
From L-glutamine catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GLS loss reduce cancer cell proliferation? | CRISPR knockout of GLS in cancer cell lines |
| Does a specific GLUD1 mutation alter ammonia handling? | Point-mutation knock-in in cell lines or mice |
| Can tagged GLS track mitochondrial localization? | Knock-in of fluorescent or epitope tag at GLS locus |
| Does GOT1 overexpression affect redox balance? | Overexpression of GOT1 in pancreatic cancer cells |
| Which transporters are required for glutamine uptake? | CRISPR knockout of SLC1A5, SLC38A2, SLC7A5 |
| Does glutamine catabolism regulate glutathione synthesis? | Knockout of GCLC or GCLM with glutamine supplementation |
How to Study the L-glutamine catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| 13C/15N glutamine tracing | Metabolic flux through catabolic enzymes | Cancer metabolism studies |
| RNA-seq | Gene expression changes | Transcriptional regulation of GLS, GLUD1 |
| Proteomics | Protein abundance and modifications | Enzyme expression in disease models |
| Metabolomics | Levels of glutamate, alpha-KG, glutathione | Redox and metabolic profiling |
| CRISPR knockout screens | Gene essentiality under glutamine stress | Discovery of new pathway regulators |
| Western blot | Protein expression and cleavage | Validation of knockout or overexpression |
| Enzyme activity assays | Glutaminase or GDH activity | Functional validation of variants |
| Immunofluorescence | Subcellular localization | Mitochondrial vs cytosolic enzymes |
Metabolic flux analysis
Stable isotope tracing with 13C/15N-labeled glutamine combined with mass spectrometry measures flux through glutaminase, glutamate dehydrogenase, and transaminases. This method quantifies how much glutamine carbon enters the TCA cycle and how much nitrogen is incorporated into other metabolites.
RNA-seq and transcriptomics
RNA sequencing can profile expression of GLS, GLUD1, GOT1, and transporters in response to genetic or pharmacological perturbations. It helps identify transcriptional programs linked to glutamine catabolism in cancer and normal tissues.
Proteomics and metabolomics
Mass spectrometry-based proteomics and metabolomics can measure enzyme abundance and metabolite levels such as glutamate, alpha-ketoglutarate, and glutathione. These approaches reveal how glutamine catabolism affects redox and biosynthetic pathways.
CRISPR screens and functional genomics
Genome-wide CRISPR knockout screens can identify genes required for growth under glutamine-limited conditions, revealing dependencies on glutamine catabolic enzymes. Such screens are powerful for discovering new regulators of GO:0006543.
How CRISPR Can Be Used to Study GO:0006543 L-glutamine catabolic process
Knockout
CRISPR knockout of GLS, GLUD1, or GOT1 can abolish specific steps in L-glutamine catabolism, allowing researchers to test their requirement for cell proliferation, redox balance, and survival. Knockout models are widely used in cancer metabolism to validate metabolic dependencies.
Point Mutation
Point mutations in GLUD1 or GLS can mimic human disease variants or alter catalytic activity, enabling structure-function studies of glutamine catabolic enzymes. CRISPR prime editing or homology-directed repair can introduce precise mutations.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) or epitope tags at endogenous GLS or GLUD1 loci allows real-time tracking of enzyme localization and dynamics. Knock-in of reporter cassettes can also monitor pathway activity.
Overexpression
Overexpression of GOT1, GLS, or SLC1A5 can drive increased glutamine catabolism and reveal sufficiency for metabolic reprogramming. Overexpression models are useful for testing whether a gene promotes proliferation or redox resistance.
How EDITGENE Supports L-glutamine catabolic process Research
Researchers studying L-glutamine catabolic process-related genes often need to determine whether a candidate gene is causally involved in metabolic rewiring, disease progression, or therapeutic response. EDITGENE provides CRISPR-based cell model services to enable such causal experiments with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for L-glutamine catabolic process research.
Frequently Asked Questions About L-glutamine catabolic process
What is L-glutamine catabolic process (GO:0006543)?
It is the set of biochemical reactions that break down L-glutamine into glutamate and ammonia, feeding carbon and nitrogen into central metabolism.
What genes are involved in L-glutamine catabolic process?
Key genes include GLS, GLS2, GLUD1, GLUD2, GOT1, GOT2, GPT, GPT2, and glutamine transporters such as SLC1A5 and SLC38A2.
Why is glutamine catabolism important in cancer?
Many cancer cells depend on glutamine catabolism for proliferation, redox balance, and biosynthesis, making it a therapeutic target.
How is L-glutamine catabolic process regulated?
It is regulated by oncogenes like MYC, nutrient availability, mTORC1 signaling, and feedback inhibition by ammonia and redox status.
What enzymes catalyze glutamine breakdown?
Glutaminase (GLS/GLS2) converts glutamine to glutamate, and glutamate dehydrogenase (GLUD1/GLUD2) converts glutamate to alpha-ketoglutarate.
Does glutamine catabolism affect glutathione?
Yes, glutamate derived from glutamine is used for glutathione synthesis, supporting redox homeostasis.
Can CRISPR be used to study glutamine catabolism?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to study genes in this pathway.
What diseases are linked to glutamine catabolism?
Cancer, sickle cell disease, and conditions involving oxidative stress and intestinal dysfunction have been linked to glutamine metabolism.
How can I measure glutamine catabolic flux?
Stable isotope tracing with 13C/15N-glutamine combined with mass spectrometry is a standard method.
What cell models are available for glutamine catabolism research?
EDITGENE provides knockout, point-mutation, knock-in, and overexpression cell models for genes in this pathway.
Conclusion
L-glutamine catabolic process (GO:0006543) is a central metabolic pathway that breaks down glutamine to support energy production, biosynthesis, and redox balance. Its dysregulation is implicated in cancer, sickle cell disease, and oxidative stress-related conditions. Understanding the genes and mechanisms involved provides opportunities for therapeutic intervention and biomarker discovery. CRISPR-based models are powerful tools for causally testing the role of individual genes in this pathway.
References
- 1. Jin J et al.. 2023. Targeting glutamine metabolism as a therapeutic strategy for cancer.. Exp Mol Med 55(4):706-715 PMID: 37009798
- 2. Labow BI et al.. 2000. Glutamine.. World J Surg 24(12):1503-13 PMID: 11193715
- 3. Kusumoto I. 2001. Industrial production of L-glutamine.. J Nutr 131(9 Suppl):2552S-5S PMID: 11533312
- 4. Rideau N et al.. 1989. L-leucine or its keto acid potentiate but do not initiate insulin release in chicken.. Am J Physiol 257(1 Pt 1):E15-9 PMID: 2665515
- 5. Jafri F et al.. 2022. L-glutamine for sickle cell disease: more than reducing redox.. Ann Hematol 101(8):1645-1654 PMID: 35568758
- 6. Fürst P et al.. 1990. Glutamine-containing dipeptides in parenteral nutrition.. JPEN J Parenter Enteral Nutr 14(4 Suppl):118S-124S PMID: 2119457
- 7. Petry ÉR et al.. 2015. L-glutamine supplementations enhance liver glutamine-glutathione axis and heat shock factor-1 expression in endurance-exercise trained rats.. Int J Sport Nutr Exerc Metab 25(2):188-97 PMID: 25202991
- 8. Liu N et al.. 2018. l-Glutamine Attenuates Apoptosis in Porcine Enterocytes by Regulating Glutathione-Related Redox Homeostasis.. J Nutr 148(4):526-534 PMID: 29659951
